Logo image of NXRT

NEXPOINT RESIDENTIAL (NXRT) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:NXRT - US65341D1028 - REIT

30.87 USD
+0.2 (+0.65%)
Last: 1/9/2026, 11:50:40 AM
Fundamental Rating

2

Overall NXRT gets a fundamental rating of 2 out of 10. We evaluated NXRT against 20 industry peers in the Residential REITs industry. Both the profitability and financial health of NXRT have multiple concerns. NXRT has a expensive valuation and it also scores bad on growth. NXRT also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year NXRT has reported negative net income.
NXRT had a positive operating cash flow in the past year.
NXRT had positive earnings in 4 of the past 5 years.
Each year in the past 5 years NXRT had a positive operating cash flow.
NXRT Yearly Net Income VS EBIT VS OCF VS FCFNXRT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200M -400M -600M

1.2 Ratios

Looking at the Return On Assets, with a value of -2.64%, NXRT is doing worse than 90.00% of the companies in the same industry.
With a Return On Equity value of -15.06%, NXRT is not doing good in the industry: 90.00% of the companies in the same industry are doing better.
Looking at the Return On Invested Capital, with a value of 1.26%, NXRT is doing worse than 70.00% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for NXRT is in line with the industry average of 2.59%.
Industry RankSector Rank
ROA -2.64%
ROE -15.06%
ROIC 1.26%
ROA(3y)0.58%
ROA(5y)1.05%
ROE(3y)2.48%
ROE(5y)4.62%
ROIC(3y)1.37%
ROIC(5y)1.09%
NXRT Yearly ROA, ROE, ROICNXRT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20

1.3 Margins

In the last couple of years the Profit Margin of NXRT has declined.
The Operating Margin of NXRT (11.35%) is worse than 70.00% of its industry peers.
In the last couple of years the Operating Margin of NXRT has grown nicely.
NXRT has a better Gross Margin (63.29%) than 90.00% of its industry peers.
NXRT's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 11.35%
PM (TTM) N/A
GM 63.29%
OM growth 3Y12.71%
OM growth 5Y7.38%
PM growth 3Y-65.59%
PM growth 5Y-62.11%
GM growth 3Y-12.32%
GM growth 5Y-7.43%
NXRT Yearly Profit, Operating, Gross MarginsNXRT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), NXRT is destroying value.
Compared to 1 year ago, NXRT has less shares outstanding
Compared to 5 years ago, NXRT has more shares outstanding
The debt/assets ratio for NXRT is higher compared to a year ago.
NXRT Yearly Shares OutstandingNXRT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
NXRT Yearly Total Debt VS Total AssetsNXRT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

NXRT has an Altman-Z score of 0.41. This is a bad value and indicates that NXRT is not financially healthy and even has some risk of bankruptcy.
NXRT has a Altman-Z score of 0.41. This is in the lower half of the industry: NXRT underperforms 60.00% of its industry peers.
NXRT has a debt to FCF ratio of 33.86. This is a negative value and a sign of low solvency as NXRT would need 33.86 years to pay back of all of its debts.
The Debt to FCF ratio of NXRT (33.86) is comparable to the rest of the industry.
NXRT has a Debt/Equity ratio of 4.55. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of NXRT (4.55) is worse than 85.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 4.55
Debt/FCF 33.86
Altman-Z 0.41
ROIC/WACC0.16
WACC7.77%
NXRT Yearly LT Debt VS Equity VS FCFNXRT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B 1.5B

2.3 Liquidity

NXRT has a Current Ratio of 0.72. This is a bad value and indicates that NXRT is not financially healthy enough and could expect problems in meeting its short term obligations.
With a decent Current ratio value of 0.72, NXRT is doing good in the industry, outperforming 65.00% of the companies in the same industry.
A Quick Ratio of 0.72 indicates that NXRT may have some problems paying its short term obligations.
NXRT has a Quick ratio of 0.72. This is in the better half of the industry: NXRT outperforms 70.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.72
Quick Ratio 0.72
NXRT Yearly Current Assets VS Current LiabilitesNXRT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

1

3. Growth

3.1 Past

NXRT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -209.25%.
NXRT shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -65.41% yearly.
NXRT shows a decrease in Revenue. In the last year, the revenue decreased by -4.46%.
NXRT shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.48% yearly.
EPS 1Y (TTM)-209.25%
EPS 3Y-70.76%
EPS 5Y-65.41%
EPS Q2Q%11.43%
Revenue 1Y (TTM)-4.46%
Revenue growth 3Y5.81%
Revenue growth 5Y7.48%
Sales Q2Q%-1.98%

3.2 Future

NXRT is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -301.87% yearly.
The Revenue is expected to grow by 1.23% on average over the next years.
EPS Next Y-6291.4%
EPS Next 2Y-726.44%
EPS Next 3Y-301.87%
EPS Next 5YN/A
Revenue Next Year-2.72%
Revenue Next 2Y-0.17%
Revenue Next 3Y1.47%
Revenue Next 5Y1.23%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
NXRT Yearly Revenue VS EstimatesNXRT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50M 100M 150M 200M 250M
NXRT Yearly EPS VS EstimatesNXRT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 -1 2 3 4

2

4. Valuation

4.1 Price/Earnings Ratio

NXRT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for NXRT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NXRT Price Earnings VS Forward Price EarningsNXRT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 60

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as NXRT.
Based on the Price/Free Cash Flow ratio, NXRT is valued cheaper than 95.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 18.06
EV/EBITDA 17.84
NXRT Per share dataNXRT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

A cheap valuation may be justified as NXRT's earnings are expected to decrease with -301.87% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-726.44%
EPS Next 3Y-301.87%

7

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 7.04%, NXRT is a good candidate for dividend investing.
NXRT's Dividend Yield is rather good when compared to the industry average which is at 11.09. NXRT pays more dividend than 85.00% of the companies in the same industry.
NXRT's Dividend Yield is rather good when compared to the S&P500 average which is at 1.94.
Industry RankSector Rank
Dividend Yield 7.04%

5.2 History

The dividend of NXRT is nicely growing with an annual growth rate of 10.88%!
NXRT has been paying a dividend for at least 10 years, so it has a reliable track record.
As NXRT did not decrease their dividend in the past 5 years, we can say the dividend looks stable.
Dividend Growth(5Y)10.88%
Div Incr Years9
Div Non Decr Years9
NXRT Yearly Dividends per shareNXRT Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

The earnings of NXRT are negative and hence is the payout ratio. NXRT will probably not be able to sustain this dividend level.
DP-109.03%
EPS Next 2Y-726.44%
EPS Next 3Y-301.87%
NXRT Yearly Income VS Free CF VS DividendNXRT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200M -400M -600M

NEXPOINT RESIDENTIAL

NYSE:NXRT (1/9/2026, 11:50:40 AM)

30.87

+0.2 (+0.65%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryResidential REITs
Earnings (Last)10-28 2025-10-28/bmo
Earnings (Next)02-23 2026-02-23/amc
Inst Owners76.86%
Inst Owner Change0%
Ins Owners13.26%
Ins Owner Change-1.14%
Market Cap782.86M
Revenue(TTM)252.99M
Net Income(TTM)-48.65M
Analysts72.86
Price Target34.34 (11.24%)
Short Float %2.8%
Short Ratio3.43
Dividend
Industry RankSector Rank
Dividend Yield 7.04%
Yearly Dividend1.93
Dividend Growth(5Y)10.88%
DP-109.03%
Div Incr Years9
Div Non Decr Years9
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)15.4%
Min EPS beat(2)12.33%
Max EPS beat(2)18.46%
EPS beat(4)3
Avg EPS beat(4)-34.15%
Min EPS beat(4)-176.12%
Max EPS beat(4)18.46%
EPS beat(8)6
Avg EPS beat(8)63.98%
EPS beat(12)7
Avg EPS beat(12)18.82%
EPS beat(16)9
Avg EPS beat(16)53.78%
Revenue beat(2)0
Avg Revenue beat(2)-1.79%
Min Revenue beat(2)-2%
Max Revenue beat(2)-1.59%
Revenue beat(4)0
Avg Revenue beat(4)-1.66%
Min Revenue beat(4)-2%
Max Revenue beat(4)-1.36%
Revenue beat(8)2
Avg Revenue beat(8)3.27%
Revenue beat(12)3
Avg Revenue beat(12)1.74%
Revenue beat(16)5
Avg Revenue beat(16)1.32%
PT rev (1m)-2.42%
PT rev (3m)-5.16%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-4.62%
EPS NY rev (1m)0%
EPS NY rev (3m)2.36%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.02%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.17%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.09
P/FCF 18.06
P/OCF 9.33
P/B 2.42
P/tB 2.42
EV/EBITDA 17.84
EPS(TTM)-1.89
EYN/A
EPS(NY)-1.33
Fwd EYN/A
FCF(TTM)1.71
FCFY5.54%
OCF(TTM)3.31
OCFY10.72%
SpS9.98
BVpS12.73
TBVpS12.73
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -2.64%
ROE -15.06%
ROCE 1.59%
ROIC 1.26%
ROICexc 1.27%
ROICexgc 1.28%
OM 11.35%
PM (TTM) N/A
GM 63.29%
FCFM 17.14%
ROA(3y)0.58%
ROA(5y)1.05%
ROE(3y)2.48%
ROE(5y)4.62%
ROIC(3y)1.37%
ROIC(5y)1.09%
ROICexc(3y)1.38%
ROICexc(5y)1.1%
ROICexgc(3y)1.43%
ROICexgc(5y)1.13%
ROCE(3y)1.73%
ROCE(5y)1.38%
ROICexgc growth 3Y22.72%
ROICexgc growth 5Y15.26%
ROICexc growth 3Y21.87%
ROICexc growth 5Y14.79%
OM growth 3Y12.71%
OM growth 5Y7.38%
PM growth 3Y-65.59%
PM growth 5Y-62.11%
GM growth 3Y-12.32%
GM growth 5Y-7.43%
F-Score4
Asset Turnover0.14
Health
Industry RankSector Rank
Debt/Equity 4.55
Debt/FCF 33.86
Debt/EBITDA 11.72
Cap/Depr 42.01%
Cap/Sales 16.04%
Interest Coverage 0.32
Cash Conversion 66.98%
Profit Quality N/A
Current Ratio 0.72
Quick Ratio 0.72
Altman-Z 0.41
F-Score4
WACC7.77%
ROIC/WACC0.16
Cap/Depr(3y)106.97%
Cap/Depr(5y)173.62%
Cap/Sales(3y)38.98%
Cap/Sales(5y)66.96%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-209.25%
EPS 3Y-70.76%
EPS 5Y-65.41%
EPS Q2Q%11.43%
EPS Next Y-6291.4%
EPS Next 2Y-726.44%
EPS Next 3Y-301.87%
EPS Next 5YN/A
Revenue 1Y (TTM)-4.46%
Revenue growth 3Y5.81%
Revenue growth 5Y7.48%
Sales Q2Q%-1.98%
Revenue Next Year-2.72%
Revenue Next 2Y-0.17%
Revenue Next 3Y1.47%
Revenue Next 5Y1.23%
EBIT growth 1Y-15.85%
EBIT growth 3Y19.26%
EBIT growth 5Y15.4%
EBIT Next Year18718%
EBIT Next 3Y489.77%
EBIT Next 5Y288.05%
FCF growth 1Y206.61%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-8.06%
OCF growth 3Y0.14%
OCF growth 5Y7.45%

NEXPOINT RESIDENTIAL / NXRT FAQ

What is the ChartMill fundamental rating of NEXPOINT RESIDENTIAL (NXRT) stock?

ChartMill assigns a fundamental rating of 2 / 10 to NXRT.


Can you provide the valuation status for NEXPOINT RESIDENTIAL?

ChartMill assigns a valuation rating of 2 / 10 to NEXPOINT RESIDENTIAL (NXRT). This can be considered as Overvalued.


What is the profitability of NXRT stock?

NEXPOINT RESIDENTIAL (NXRT) has a profitability rating of 3 / 10.


What is the financial health of NEXPOINT RESIDENTIAL (NXRT) stock?

The financial health rating of NEXPOINT RESIDENTIAL (NXRT) is 2 / 10.


What is the expected EPS growth for NEXPOINT RESIDENTIAL (NXRT) stock?

The Earnings per Share (EPS) of NEXPOINT RESIDENTIAL (NXRT) is expected to decline by -6291.4% in the next year.